NCT05447416 Intermittent Hypoxic Training (IHT) Versus Hyperbaric Oxygen Therapy (HBOT) for Aerobic Performance
| NCT ID | NCT05447416 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assaf-Harofeh Medical Center |
| Condition | Healthy Active Athletes |
| Study Type | INTERVENTIONAL |
| Enrollment | 66 participants |
| Start Date | 2023-06-01 |
| Primary Completion | 2027-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 66 participants in total. It began in 2023-06-01 with a primary completion date of 2027-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Comparing the effect of HBOT and IHT on aerobic performance of athletes.
Eligibility Criteria
Inclusion Criteria: 1. Vo2max above 3500 ml or Vo2max/kg above 50 ml/kg 2. Age 18-45 3. Subjects are active aerobic athletes, training regularly more than 4 exercise sessions per week. 4. Subject willing and able to read, understand and sign an informed consent Exclusion Criteria: 1. Inability to attend scheduled clinic visits and/or comply with the study protocol 2. Active malignancy 3. Active smokers 4. Previous treatment of HBOT for any reason prior to study enrollment. 5. Chest pathology incompatible with pressure changes 6. Major orthopedic injury at the past 3 months 7. Inner ear disease 8. Lung pathology 9. The inability to perform an awake brain MRI 10. Claustrophobia 11. Previous neurologic conditions (e.g., Epilepsy, Brain tumors or s/p neurosurgery etc.) 12. Comorbidities and medications that rule out the subject
Contact & Investigator
Shai a Efrati, MD
PRINCIPAL INVESTIGATOR
Asaf-Harofhe MC
Frequently Asked Questions
Who can join the NCT05447416 clinical trial?
This trial is open to male participants only, aged 18 Years or older, up to 45 Years, studying Healthy Active Athletes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05447416 currently recruiting?
Yes, NCT05447416 is actively recruiting participants. Contact the research team at efratishai@outlook.com for enrollment information.
Where is the NCT05447416 trial being conducted?
This trial is being conducted at Zrifin, Israel.
Who is sponsoring the NCT05447416 clinical trial?
NCT05447416 is sponsored by Assaf-Harofeh Medical Center. The principal investigator is Shai a Efrati, MD at Asaf-Harofhe MC. The trial plans to enroll 66 participants.